Back to Search
JULIAN ROSENMAN, M.D., PH.D.
M.D., PH.D.
Radiation Oncology Physician
NPI: 1306945423Individual
Specialties, Licenses & Credentials
Radiation Oncology PhysicianPrimary
Radiology — Radiation Oncology
Code: 2085R0001X
25415(NC)
Research & Publications (20)
Does more aggressive therapy improve outcomes in the treatment of unresectable stage III non-small cell lung cancer?
PMID 16015531·Semin Oncol·2005
6-review
Can the use of amifostine improve cure rates for patients with advanced non-small cell lung cancer?
PMID 15726524·Semin Oncol·2004
8-other
High-dose conformal radiotherapy for treatment of stage IIIA/IIIB non-small-cell lung cancer: technical issues and results of a phase I/II trial.
PMID 12243807·Int J Radiat Oncol Biol Phys·2002
3-trial
Incorporating functional imaging information into radiation treatment.
PMID 11146045·Semin Radiat Oncol·2001
6-review
Late complications of high-dose (>/=66 Gy) thoracic conformal radiation therapy in combined modality trials in unresectable stage III non-small cell lung cancer.
PMID 19096310·J Thorac Oncol·2009
3-trial
Induction chemotherapy with carboplatin, irinotecan, and paclitaxel followed by high dose three-dimension conformal thoracic radiotherapy (74 Gy) with concurrent carboplatin, paclitaxel, and gefitinib in unresectable stage IIIA and stage IIIB non-small cell lung cancer.
PMID 18317067·J Thorac Oncol·2008
4-observational
Long-term follow-up of a phase I/II trial of dose escalating three-dimensional conformal thoracic radiation therapy with induction and concurrent carboplatin and paclitaxel in unresectable stage IIIA/B non-small cell lung cancer.
PMID 18978563·J Thorac Oncol·2008
3-trial
Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer: CALGB 30105.
PMID 18487565·J Clin Oncol·2008
3-trial
Synergistic mutations produce blue-shifted bioluminescence in firefly luciferase.
PMID 17994766·Biochemistry·2007
8-other
Therapeutic advances in local-regional therapy for stage III non-small-cell lung cancer: evolving role of dose-escalated conformal (3-dimensional) radiation therapy.
PMID 17239295·Clin Lung Cancer·2006
6-review
Post-chemotherapy gross tumor volume is predictive of survival in patients with stage III non-small cell lung cancer treated with combined modality therapy.
PMID 16499996·Lung Cancer·2006
8-other
Automatic segmentation of intra-treatment CT images for adaptive radiation therapy of the prostate.
PMID 16685876·Med Image Comput Comput Assist Interv·2005
3-trial
Large deformation three-dimensional image registration in image-guided radiation therapy.
PMID 16333161·Phys Med Biol·2005
8-other
Chemotherapeutic issues in the management of unresectable stage III non-small cell lung cancer.
PMID 16015532·Semin Oncol·2005
6-review
Bronchial stenosis: an underreported complication of high-dose external beam radiotherapy for lung cancer?
PMID 15629595·Int J Radiat Oncol Biol Phys·2005
8-other
Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer.
PMID 15570087·J Clin Oncol·2004
1-meta
Compensators: an alternative IMRT delivery technique.
PMID 15753937·J Appl Clin Med Phys·2004
4-observational
Induction and concurrent chemotherapy with high-dose thoracic conformal radiation therapy in unresectable stage IIIA and IIIB non-small-cell lung cancer: a dose-escalation phase I trial.
PMID 15514375·J Clin Oncol·2004
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 101 MANNING DR
CHAPEL HILL, ND 27599 - Phone
- (919) 966-4131
Quick Facts
- NPI
- 1306945423
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile